How prenatal cannabis exposure alters brain chemistry in offspring
A review of animal and human research found that prenatal cannabinoid exposure causes widespread alterations to neurotransmitter systems in offspring that are region-specific, time-dependent, and sexually dimorphic.
Quick Facts
What This Study Found
Prenatal cannabinoid exposure alters multiple neurotransmitter systems including dopamine, serotonin, GABA, glutamate, and opioid systems. These changes are brain region-specific, develop at different time points, and differ between male and female offspring. Human studies show deficits in attention and executive function in exposed children.
Key Numbers
Alterations documented across dopamine, serotonin, GABA, glutamate, and endogenous opioid systems. Changes were region-specific and sexually dimorphic.
How They Did This
Narrative review summarizing observed neurotransmitter changes from animal and human studies of prenatal cannabinoid exposure, including both marijuana and synthetic cannabinoids.
Why This Research Matters
Marijuana use during pregnancy is steadily increasing despite evidence of harm. Understanding exactly which brain systems are affected helps explain the behavioral deficits observed in exposed children and underscores the biological basis for concern.
The Bigger Picture
With synthetic cannabinoid use also rising among young adults, the concern extends beyond marijuana. The finding that effects are sexually dimorphic means male and female children may show different patterns of vulnerability.
What This Study Doesn't Tell Us
Much of the evidence comes from animal studies using specific cannabinoid compounds that may not perfectly replicate human marijuana use. Human studies are confounded by polydrug use and socioeconomic factors.
Questions This Raises
- ?Are there critical windows during pregnancy when exposure is most harmful?
- ?Do the neurotransmitter changes persist into adulthood or normalize over time?
- ?Are synthetic cannabinoids more harmful prenatally than plant-derived cannabis?
Trust & Context
- Key Stat:
- Neurotransmitter changes were sexually dimorphic
- Evidence Grade:
- Moderate: comprehensive narrative review of animal and human data, though much evidence is preclinical.
- Study Age:
- Published in 2019.
- Original Title:
- Prenatal cannabinoid exposure and altered neurotransmission.
- Published In:
- Neuropharmacology, 149, 181-194 (2019)
- Authors:
- Pinky, Priyanka D(3), Bloemer, Jenna(3), Smith, Warren D(2), Moore, Timothy, Hong, Hao, Suppiramaniam, Vishnu, Reed, Miranda N
- Database ID:
- RTHC-02232
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does "sexually dimorphic" mean in this context?
It means the neurotransmitter changes caused by prenatal cannabinoid exposure differed between male and female offspring, suggesting that sex influences vulnerability to these effects.
Does this apply to CBD use during pregnancy?
The review focused primarily on THC and synthetic cannabinoids. The effects of prenatal CBD exposure are less studied and were not a major focus of this review.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-02232APA
Pinky, Priyanka D; Bloemer, Jenna; Smith, Warren D; Moore, Timothy; Hong, Hao; Suppiramaniam, Vishnu; Reed, Miranda N. (2019). Prenatal cannabinoid exposure and altered neurotransmission.. Neuropharmacology, 149, 181-194. https://doi.org/10.1016/j.neuropharm.2019.02.018
MLA
Pinky, Priyanka D, et al. "Prenatal cannabinoid exposure and altered neurotransmission.." Neuropharmacology, 2019. https://doi.org/10.1016/j.neuropharm.2019.02.018
RethinkTHC
RethinkTHC Research Database. "Prenatal cannabinoid exposure and altered neurotransmission." RTHC-02232. Retrieved from https://rethinkthc.com/research/pinky-2019-prenatal-cannabinoid-exposure-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.